Inventor

Niva Yacov

Inventor

Tel Aviv, IL

Overview

12→

Patents

2009–2019

Patent span

Human necessities

Primary field (CPC A)

Patents· 12 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium20%

A61KPreparations for medical, dental or toiletry purposes18%

Y02ATechnologies for adaptation to climate change15%

C07CAcyclic or carbocyclic compounds13%

B82YSpecific uses or applications of nanostructures12%

A01NPreservation of bodies of humans or animals or plants or parts thereof2%

PatentTitleYear

10,464,957Oxidized lipids and methods of use thereof2019 10,206,936Oxidized lipids and treatment or prevention of fibrosis2019 10,022,388Oxidized lipids and treatment or prevention of fibrosis2018 9,771,385'Oxidized lipids'2017 9,206,206'Oxidized lipid compounds and uses thereof'2015 8,563,534'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'2013 8,501,715'Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders'2013 8,158,611'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'2012 7,973,023'Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders'2011 7,902,176'Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders'2011 7,893,291'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'2011 7,504,388'Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2019Patents assigned to VASCULAR BIOGENICS LTD (12)· patent assignee history

2009–2019Based in Tel Aviv, IL· patent location history

2012–2015Patents assigned to HALPERIN GIDEON (4)· patent assignee history

2012–2015Patents assigned to KOVALEVSKI-ISHAI ETI (4)· patent assignee history

2012–2015Patents assigned to YACOV NIVA (4)· patent assignee history

2012–2013Patents assigned to GEORGE JACOB (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
VASCULAR BIOGENICS LTD	12	2009–2019
HALPERIN GIDEON	4	2012–2015
KOVALEVSKI-ISHAI ETI	4	2012–2015
YACOV NIVAself	4	2012–2015
GEORGE JACOB	3	2012–2013

Locations

Location	Patents	Span
Tel Aviv, IL	12	2009–2019